Skip to main content
. 2021 Nov 1;2021:2048833. doi: 10.1155/2021/2048833

Figure 3.

Figure 3

Patient characteristics in the high- and low-risk groups in the testing and whole sets. (a, f) Survival distribution of high- and low-risk patients. (b, g) ROC curves predicting 1-, 3-, and 5-year survival rates. (c, h) Expression of the 8 miRNAs changed with increasing risk score. Comparisons of somatic mutation count and UBQLN4 expression in the high- and low-risk groups in the (d, e) testing and (i, j) whole TCGA sets.